- ICH GCP
- US Clinical Trials Registry
- Researchers
- Japan
- Lung Neoplasms
Medical specialists from Japan tagged as investigators in clinical trials studying Lung Neoplasms
Total 60 results
-
Ryo AriyasuSeen in:
- Koto-ku, Cancer Institute Hospital of JFCR
- Tokyo, Koto, Cancer Institute Hospital of JFCR
- Tokyo, Koto, Japanese Foundation for Cancer Research
Trials:- NCT05882734 (Principal Investigator)
- NCT05973773 (Principal Investigator)
- NCT06119581 (Principal Investigator)
-
Ryo ToyozawaSeen in:
- Fukuoka, National Hospital Organization Kyushu Cancer Center
Trials:- NCT03157128 (Principal Investigator)
-
Ryoji Kato, MDSeen in:
- Chiba, Sakura, Toho University Sakura Medical Center
Trials:- NCT00546130 (Principal Investigator)
Conditions: -
Satoru Kitazono, MD, PhDSeen in:
- Tokyo, The Cancer Institute Hospital of Japanese Foundation for Cancer Research
Trials:- NCT04036682 (Principal Investigator)
Conditions: -
Satoshi Oizumi, MDSeen in:
- Hokkaido, Sapporo, Hokkaido University Hospital
Trials:- NCT00546130 (Principal Investigator)
Conditions: -
Satoshi WatanabeSeen in:
- Niigata, Niigata City, Niigata University Medical and Dental Hospital
Trials:- NCT03811002 (Principal Investigator)
-
Shigeki Umemura, MD, PhDSeen in:
- Chiba, National Cancer Center Hospital East
Trials:- NCT04036682 (Principal Investigator)
Conditions: -
Shinichiro SuzukiSeen in:
- Osakasayama-shi, Kindai University Hospital
Trials:- NCT05882734 (Principal Investigator)
Conditions: -
Shinji TakeuchiSeen in:
- Ishikawa, Kanazawa, Kanazawa University Hospital
Trials:- NCT03906331 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT06119581 (Principal Investigator)
-
Shoichiro YamamotoSeen in:
- Ehime, Toon, Ehime University Hospital
Trials:- NCT03811002 (Principal Investigator)
-
Takayasu KurataSeen in:
- Hirakata-shi, Kansai Medical University Hospital
- Osaka, Hirakata, Kansai Medical University Hospital
- Osaka, Takatsuki, Osaka Medikal College Hospital
Trials:- NCT05882734 (Principal Investigator)
- NCT05973773 (Principal Investigator)
- NCT06119581 (Principal Investigator)
- NCT00546130 (Principal Investigator)
-
Takeshi Fujii, MD/PhDSeen in:
- Tokyo, The Institute of Medical Science, The University of Tokyo
Trials:- NCT00673777 (Principal Investigator)
Conditions: -
Tatsuhiko Kashii, MD, PhDSeen in:
- Toyama, Toyama University Hospital
Trials:- NCT00546130 (Principal Investigator)
Conditions: -
Tatsuya Yoshida, MDSeen in:
- Tokyo, Chuo-ku, National Cancer Center Hospital
Trials:- NCT05241873 (Principal Investigator)
Conditions:- Neoplasms;
- Neoplasms by Histologic Type;
- Lung Diseases;
- Neoplasms by Site;
- Adenocarcinoma;
- Carcinoma;
- Carcinoma, Non-Small-Cell Lung;
- Respiratory Tract Neoplasms;
- Carcinoma, Bronchogenic;
- Bronchial Neoplasms;
- Metastatic Lung Cancer;
- Antineoplastic Agents;
- Brain Metastases;
- Lung Neoplasm Malignant;
- EGFR Activating Mutation;
- Respiratory Tract Disease;
- EGFR Exon 20 Mutation;
- EGFR Exon 20 Insertion Mutation;
- EGFR-mutated NSCLC;
- EGFR Atypical Mutations, Including G719X and L861Q
-
Terufumi KatoSeen in:
- Kanagawa, GSK Investigational Site
- Kanagawa, Yokohama, Hikita Pediatric Clinic
- Kanagawa, Yokohama, Kanagawa Cancer Center
Trials:- NCT04819100 (Principal Investigator)
- NCT05565378 (Principal Investigator)
-
Tetsuya SakaiSeen in:
- Chiba, GSK Investigational Site
- Kashiwa-shi, National Cancer Center Hospital East
Trials:- NCT05565378 (Principal Investigator)
- NCT05882734 (Principal Investigator)
Conditions: -
Tomohiro SakamotoSeen in:
- Tottori, Yonago, Respiratory medicine and Rheumatology
- Tottori, Yonago, Tottori University Hospital
Trials:- NCT04819100 (Principal Investigator)
- NCT03906331 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT06119581 (Principal Investigator)
-
Tomonori Hirasima, MDSeen in:
- Osaka, Habikino, Osaka Prefectural Medical Center for Respiratory and Allergic Diseases
Trials:- NCT00546130 (Principal Investigator)
Conditions: -
Toshio Shimizu, MDSeen in:
- Nara, Ikoma, Kinkidaigakuigakubu Nara Hospital
Trials:- NCT00546130 (Principal Investigator)
Conditions: -
TOSHIYUKI KOZUKISeen in:
- Ehime, Matsuyama, National Hospital Organization Shikoku Cancer Center
- Matsuyama, Shikoku Cancer Center
Trials:- NCT03811002 (Principal Investigator)
- NCT06119581 (Principal Investigator)
-
Tsutomu IwasaSeen in:
- Osaka, Osaka Sayama-shi, Kindai University Hospital
- Other, Osakasayama-Shi, Kindai University Hospital
Trials:- NCT03157128 (Principal Investigator)
- NCT05132582 (Principal Investigator)
-
Uchibori KenSeen in:
- Koto-Ku, Cancer Institute Hospital of JFCR
Trials:- NCT05765734 (Principal Investigator)
Conditions: -
Yasuo Iwamoto, MDSeen in:
- Hiroshima, Hiroshima City Hospital
Trials:- NCT00546130 (Principal Investigator)
Conditions: -
Yosuke MiuraSeen in:
- Maebashi, Gunma, Gunma University Hospital
Trials:- NCT03811002 (Principal Investigator)
-
YUICHIRO OHESeen in:
- Tokyo, Chuo-ku, National Cancer Center Hospital
- Tokyo, National Cancer Center Hospital
Trials:- NCT03906331 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT04036682 (Principal Investigator)
-
Yuji Shibata, MD, PhDSeen in:
- Chiba, Kashiwa, National Cancer Center Hospital East
Trials:- NCT05241873 (Principal Investigator)
Conditions:- Neoplasms;
- Neoplasms by Histologic Type;
- Lung Diseases;
- Neoplasms by Site;
- Adenocarcinoma;
- Carcinoma;
- Carcinoma, Non-Small-Cell Lung;
- Respiratory Tract Neoplasms;
- Carcinoma, Bronchogenic;
- Bronchial Neoplasms;
- Metastatic Lung Cancer;
- Antineoplastic Agents;
- Brain Metastases;
- Lung Neoplasm Malignant;
- EGFR Activating Mutation;
- Respiratory Tract Disease;
- EGFR Exon 20 Mutation;
- EGFR Exon 20 Insertion Mutation;
- EGFR-mutated NSCLC;
- EGFR Atypical Mutations, Including G719X and L861Q
-
Yuki ShinnoSeen in:
- Chuo-ku, National Cancer Center Hospital
Trials:- NCT05882734 (Principal Investigator)
Conditions: -
Yutaka FujiwaraSeen in:
- Aichi, Nagoya, Aichi Cancer Center Hospital
- Aiti [Aichi], Nagoya, Aichi Cancer Center
- Nagoya-shi, Aichi Cancer Center Hospital
Trials:- NCT05882734 (Principal Investigator)
- NCT05973773 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Clinical Trials on Lung Neoplasms
-
Oliver JonasMassachusetts General HospitalCompletedLung Cancer | Lung TumorUnited States
-
C. R. BardCompleted
-
Azienda Sanitaria-Universitaria Integrata di UdineRecruitingLung Diseases | Lung Cancer | Lung Adenocarcinoma | Lung Transplant Rejection | Lung; Node | Lung TBItaly
-
UNC Lineberger Comprehensive Cancer CenterSivan Innovation Ltd.CompletedLung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of LungUnited States
-
Washington University School of MedicineVarian Medical SystemsRecruitingLung Cancer | Oligometastatic Lung TumorUnited States
-
Baptist Health South FloridaWithdrawnLung Cancer | Lung TumorUnited States
-
University of UtahRecruitingLung Cancer | Lung Neoplasms/DiagnosisUnited States
-
Portsmouth Hospitals NHS TrustCompletedLung Cancer | Interstitial Lung DiseaseUnited Kingdom
-
Noah MedicalRecruitingLung Cancer | Nodes, LungHong Kong
-
Massachusetts General HospitalAgency for Healthcare Research and Quality (AHRQ)Recruiting